Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
We are pleased to announce and welcome Mary Ann Besser as director of marketing, responsible for the overall marketing operations, driving product sales and visibility, and executing strategic marketing programs to achieve key business objectives.
Besser brings a successful record in solutions marketing, content development, demand generation, and sales support. Most recently, she was a senior manager of marketing programs in the healthcare division of Nuance Communications.
She earned her M.B.A. degree from Cardinal Stritch University, and a B.A. in English composition and business at the University of Wisconsin, Eau Claire.